Stem cells – potency, therapeutic cloning and iPS cells
BiologyCell BiologyAges 15–16
How do you mainly use this simulation?
Use it with your class: students open it from a link or a QR code, with no account needed.
A lineage tree from the zygote: pick a starting cell (a zygote, an embryonic stem cell, an adult bone-marrow stem cell, a heart muscle stem cell or a plant meristem cell), watch which specialised cell types it can become, and classify each one as totipotent, pluripotent, multipotent or unipotent. A second screen follows therapeutic cloning as a textbook diagram (the patient's nucleus put into an enucleated donor egg, an early embryo, embryonic stem cells taken and made into the cells needed) against stem cells from a spare IVF embryo, and shows why one transplant is rejected and the other is not. A third screen adds transcription factors to a patient's skin cell to make induced pluripotent stem (iPS) cells. Every route records the cell types it can reach and its rejection risk, and the benefits, risks and ethical points are listed neutrally.
Lesson: Stem cells: totipotent, pluripotent, multipotent and unipotent cells; plant meristems; therapeutic cloning; induced pluripotent stem cells; uses, risks and ethical issues
What it shows
A stem cell can divide and differentiate into other cell types, and its potency says how many. A totipotent zygote forms every cell, including the placenta; pluripotent embryonic stem cells form every body cell; multipotent adult stem cells, such as those in bone marrow, form a few related types; unipotent cells form one type. Plant meristems make every plant cell type throughout life. Embryonic stem cells from therapeutic cloning, and iPS cells reprogrammed by transcription factors, carry the patient's genes, so they are not rejected. The tree is simplified and the yields are illustrative.
How to use
On 1. Potency tree, choose the Starting cell or tap it in the tree, then press Differentiate; each run adds a row to the table. On 2. Therapeutic cloning, choose the Source of the embryo and the Cells needed, then press Run or Step through the route. On 3. iPS cells, tick the Transcription factors added, choose the Cells needed and press Reprogram; each trial records its iPS colonies.
Parameters you can change
- Screen Potency tree, Therapeutic cloning, iPS cells
- Starting cell Zygote (fertilised egg), Embryonic stem cell, Adult stem cell (bone marrow), Heart muscle stem cell, Plant meristem cell
- Source of the embryo Patient's nucleus in a donor egg (therapeutic cloning), Spare IVF embryo from a donor couple
- Cells needed Pancreatic β-cells (type 1 diabetes), Nerve cells (spinal cord injury), Heart muscle cells (after a heart attack)
- Oct4
- Sox2
- Klf4
- c-Myc
Questions to explore
- Why can a zygote grow into a whole new individual, while an embryonic stem cell on its own cannot?
- Why are cells made by therapeutic cloning or from iPS cells not rejected by the patient's immune system?
- Which ethical objections to embryonic stem cells do iPS cells avoid, and what risks remain?